Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 48, 2005, Pages 17436-17441

  Patel, Hiral J ^a   Ramkissoon, Shakti H ^a,b   Patel, Prem S ^c   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

^c BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Bone marrow metastasis; Breast cancer; Cytokines; Substance P; Tachykinin

Indexed keywords

CYTOKINE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; PEPTIDE; PREPROTACHYKININ A; SUBSTANCE P; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; BREAST CELL; CANCER CELL; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESENSITIZATION; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; GENE VECTOR; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; MALIGNANT TRANSFORMATION; NK1 GENE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TAC1 GENE; TUMOR GROWTH; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; CYTOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; PROTEIN PRECURSORS; RECEPTORS, NEUROKININ-1; TACHYKININS;

EID: 28444459876     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0506351102     Document Type: Article

References (29)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. & Thun, M. J. (2003) CA Cancer J. Clin. 53, 5-26.
2. Mundy, G. R. (2002) Nat. Rev. Cancer 2, 584-593.
3. Singh, D., Joshi, D. D., Hameed, M., Qian, J., Gascón, P., Maloof, P. B., Mosenthal, A. & Rameshwar, P. (2000) Proc. Natl. Acad. Sci. USA 97, 388-393.
4. Grotzer, M. A., Janss, A. J., Fung, K. M., Biegel, J. A., Sutton, L. N., Rorke, L. B., Zhao, H., Cnaan, A., Phillips, P. C., Lee, V. M. Y., et al. (2000) J. Clin. Oncol. 18, 1027-1035.
5. Heppeler, A., Froidevaux, S., Eberle, A. N. & Maecke, H. R. (2000) Curr. Med. Chem. 7, 971-994.
6. Hennig, I. M., Laissue, J. A., Horisberger, U. & Reubi, J. C. (1995) Int. J. Cancer 61, 786-792.
7. Moharita, A., Harrison, J. S. & Rameshwar, P. (2004) Drug Des. Rev. Online 1, 297-302.
8. Heasley, L. E. (2001) Oncogene 20, 1563-1569.
9. Rao, G., Patel, P. S., Idler, S. P., Maloof, P., Gascon, P., Potian, J. A. & Rameshwar, P. (2004) Cancer Res. 64, 2874-2881.
10. Friess, H., Zhu, Z., Liard, V., Shi, X., Shrikhande, S. V., Wang, L., Lieb, K., Korc, M., Palma, C., Zimmermann, A., et al. (2003) Lab. Invest. 83, 731-742.
11. Palma, C. & Maggi, C. A. (2000) Life Sci. 67, 985-1001.
12. Leeman, S. E. & Ferguson, S. L. (2000) Neuropeptides 34, 249-254.
13. Quartara, L. & Maggi, C. A. (1997) Neuropeptides 31, 537-563.
14. Greco, S. J., Corcoran, K. E., Cho, K. J. & Rameshwar, P. (2004) Front. Biosci. 9, 1782-1793.
15. Bandari, P. S., Qian, J., Oh, H. S., Potian, J. A., Yehia, G., Harrison, J. S. & Rameshwar, P. (2003) J. Neuroimmunol. 138, 65-75.
16. Joshi, D. D., Dang, A., Yadav, P., Qian, J., Bandari, P. S., Chen, K., Donnelly, R., Castro, T., Gascón, P., Haider, A., et al. (2001) Blood 98, 2697-2706.
17. Fong, T. M., Andersen, S. A., Yu, H., Huang, R. R. & Strader, C. D. (1992) Mol. Pharmacol. 41, 24-30.
18. Oh, H. S., Moharita, A., Potian, J. G., Whitehead, I. P., Livingston, J. C., Castro, T. A., Patel, P. S. & Rameshwar, P. (2004) Cancer Res. 64, 6327-6336.
19. Dery, O., Defea, K. A. & Bunnett, N. W. (2001) Am. J. Physiol 280, C1097-C1106.
20. Li, H., Leeman, S. E., Slack, B. E., Hauser, G., Saltsman, W. S., Krause, J. E., Blusztajn, J. K. & Boyd, N. D. (1997) Proc. Natl. Acad. Sci. USA 94, 9475-9480.
21. Alblas, J., van Etten, I. & Moolenaar, W. H. (1996) EMBO J. 15, 3351-3360.
22. Beaujouan, J. C., Torrens, Y., Saffroy, M., Kemel, M. L. & Glowinski, J. (2004) Peptides 25, 339-357.
23. Mackay, H. J. & Twelves, C. J. (2003) Endocrine-Related Cancer 10, 389-396.
24. MacKinnon, A. C., Waters, C., Rahman, I., Harani, N., Rintoul, R., Haslett, C., Sethi, T. (2000) Br. J. Cancer 83, 941-948.
25. Dimri, R., Sharabi, Y. & Shoham, J. (2000) J. Immunol. 164, 2479-2486.
26. Pelletier, L., Angonin, R., Regnard, J., Fellmann, D. & Charbord, P. (2002) Br. J. Haematol. 119, 1083-1089.
27. Fan, T. P., Hu, D. E., Guard, S., Gresham, G. A. & Watling, K. J. (1993) Br. J. Pharmacol. 110, 43-49.
28. Pennefather, J. N., Lecci, A., Candenas, M. L., Patak, E., Pinto, F. M. & Maggi, C. A. (2004) Life Sci. 74, 1445-1463.
29. Singletary, S. E., Allred, C., Ashley, P., Bassett, L. W., Berry, D., Bland, K. L., Borgen, P. I., Clark, G., Edge, S. B., Hayes, D. F., et al. (2002) J. Clin. Oncol. 20, 3628-3636.